Formulary restrictions on brand name noninsulin antihyperglycemic drugs have little impact on treatment intensification patterns among low-income patients with diabetes in Medicare Part D.
Catherine E. Cooke, PharmD
Advertisement
Articles by Catherine E. Cooke, PharmD
This retrospective study found no benefit of a disease management program compared with usual care on utilization of secondary prevention pharmacotherapies in postmyocardial infarction patients.
Advertisement
Latest Updated Articles
- Pharmacotherapy After Myocardial Infarction: Disease Management Versus Usual Care
Published: June 7th 2008 | Updated:
- Impact of Formulary Restrictions on Medication Intensification in Diabetes Treatment
Published: May 7th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Promises and Pitfalls of AI in Health Care
2
Paul Ryan Champions Health Care Policy Reform, AI Amid Government Shutdown
3
Zanubrutinib Safe, Effective in Real-World CLL/SLL Cohort
4
Review Outlines Shared Pathways Between CKD, VHD
5
